Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
UN Experts Condemn Attacks on Sudan Healthcare System
UN experts condemned the relentless attacks on Sudan’s hospitals and medical staff, citing 217 incidents since April 2025, including a March 20 strike on Al Deain Teaching Hospital that left 64 injured, 13 of them children. They warned that the health system is on the brink of collapse, with 34 million people needing humanitarian aid amid widespread displacement and starvation. The experts called on the international community to move beyond condemnations and enforce UN Security Council Resolution 2286, which bars attacks on medical facilities. Failure to act could constitute international crimes.
The Effects of Ketogenic Diet and Calorie-Restricted Diet on Metabolic Dysfunction-Associated Steatotic Liver Disease: A Retrospective Study
A retrospective cohort of 102 MASLD patients compared a 12‑week ketogenic diet (KD) with a calorie‑restricted diet (CRD). The KD produced a markedly larger drop in hepatic steatosis, with median CAP reduction of 62 dB/m versus 36 dB/m for CRD, and 84%...
Pre-Existing Iron Deficiency Anemia and Long-Term Risk of Recurrent Acute Kidney Injury in Survivors of ICU-Associated AKI: A Propensity-Matched Study
A large propensity‑score‑matched study of 13,002 ICU patients with acute kidney injury (AKI) found that pre‑existing iron deficiency anemia (IDA) markedly raises the risk of recurrent AKI (rAKI) over the next three years. The hazard ratio for rAKI was 1.53,...
GLP-1s: Is the Industry Asking the Wrong Question?
GLP‑1 medications now reach roughly 13.3% of U.S. consumers and could climb to about 21% by 2030, prompting a reevaluation of food‑category impacts. Industry research from the American Bakers Association shows that rather than abandoning baked‑goods, users are eating smaller...
AI Body Composition Tool Predicts Future Health Risks
Researchers at University Medical Center Freiburg used an AI‑driven deep‑learning framework to analyze whole‑body MRI scans from 66,608 participants, creating the most detailed age‑, sex‑ and height‑adjusted body‑composition reference map to date. The study showed that skeletal‑muscle quality and visceral...
Hong Kong Reviews Safeguards for Shared Use of Elderly Health Care Vouchers
Hong Kong’s Department of Health is tightening controls on the Elderly Health Care Voucher (EHCV) scheme after discovering misuse of vouchers belonging to deceased spouses. Since July 2023, more than 178,000 elderly couples have linked accounts, generating over 670,000 shared...
Multi4 Medical Receives CE Mark Approval for Multi4 System to Perform Outpatient Bladder Cancer Treatment
Multi4 Medical has secured CE mark approval for its Multi4 System, an integrated endoscopic platform that enables bladder cancer treatment in a single outpatient visit. The device delivers local anesthesia, performs tumor resection, extracts tissue for pathology, and cauterizes—all without...
Hamilton Medical Selects PTC Codebeamer ALM
Hamilton Medical has selected PTC’s Codebeamer Application Lifecycle Management (ALM) platform to replace its legacy system and paper‑based processes. The new solution will integrate with PTC’s Windchill PLM to provide a unified product data foundation, enabling automated traceability, audit readiness,...
What’s Next for Cervical Spine Tech and Startup Synergy Spine Solutions
Synergy Spine Solutions received FDA pre‑market clearance for its Synergy Disc, a cervical artificial disc that mimics a ball‑and‑socket hip joint to improve spinal alignment while preserving full range of motion. The implant uses a patented geometry and is offered...
Doctolib Plans for £100m UK Investment Into Digital Primary Care Acquiring Medicus
Doctolib announced a £100 million (≈$125 million) investment to acquire UK digital‑health firm Medicus, creating a 150‑person R&D centre in London. The partnership will combine Medicus’s NHS primary‑care expertise with Doctolib’s AI platform, which already serves over 40,000 European GPs. The move...
Opera Singer Who Hid Deafness for 30 Years Hails ‘Life-Changing’ Surgery
London mezzo‑soprano Janine Roebuck, 72, underwent bilateral cochlear‑implant surgery after privately funding a second implant, describing the outcome as "life‑changing." The procedure is part of a NIHR‑backed trial comparing one versus two implants in more than 250 adult NHS patients. Current...
Addressing Treatment Gaps in Gout
In this episode, Crystallis Therapeutics CEO James McKay explains the biology of gout, why existing urate‑lowering drugs often fail, and how the company’s next‑generation URAT1 inhibitor, detenurad, aims to close the large treatment gap for moderate‑to‑severe patients. He highlights that...
2026 World Pediatrics Conference | October 05-06 | Osaka, Japan
The 2026 World Pediatrics Conference (2026WPC) will take place in Osaka, Japan on October 5‑6, 2026. The two‑day event gathers pediatricians, nurses, researchers and industry professionals to present the latest findings across a broad spectrum of specialties. Sessions will address neonatal care,...
Popular GLP-1 Drugs Significantly Reduce Major Cardiovascular Events,
A systematic review and meta‑analysis of eleven cardiovascular outcome trials involving 91,490 high‑risk patients found that GLP‑1 receptor agonists reduce major adverse cardiovascular events (MACE) by 14% compared with placebo. The therapy also lowered cardiovascular mortality by 13% and improved...
Power, Policy, and Public Health in South Asia: A Narrative Review with Emphasis on Pakistan
The paper reviews how political factors shape health outcomes in South Asia, focusing on Pakistan. It highlights that governance weaknesses, corruption, and the post‑18th Constitutional Amendment fragmentation impede health‑system performance. Despite successes from the Sehat Sahulat insurance scheme and the...
The Latest 10 Top Discoveries in Dentistry This Week
The Science Briefing post highlights the ten most influential dentistry discoveries reported this week, spanning regenerative therapies, artificial‑intelligence diagnostics, and advanced materials. Researchers unveiled stem‑cell scaffolds that accelerate dentin repair, AI‑driven imaging that spots early caries with near‑clinical accuracy, and...
24/7 GP Appointment Booking Is Now Live in the NHS App for More than One Million Patients
Rapid Health’s AI‑driven Smart Triage is now live in the NHS App, giving more than one million English patients 24/7 access to GP appointments. The integration offers each user an average of 61 time slots, with most bookings occurring within...
GLP Podcast: ‘Safe Injection Sites’: Enabling Drug Addiction or Saving Lives?
In this episode of the Facts and Fallacies podcast, host Cameron English and medical toxicologist Dr. Liza Lockwood debate the merits of safe injection sites as a response to the U.S. opioid overdose crisis. They examine arguments that such facilities...
Digital Approach Needed for Patient Flow
A new Public Policy Projects report argues that NHS patient‑flow problems stem from governance failures rather than technology gaps. It calls for whole‑system digital intelligence paired with redesigned workflows, clear accountability, and cultural change. The paper proposes four recommendations, including...
Need to See a Psychologist? How to Find One That’s Right for You
In Australia, a GP can refer a patient to a psychologist under a mental health treatment plan, unlocking Medicare rebates for up to ten sessions a year. The referral does not lock the patient into a specific practitioner, allowing them...
Aurobindo Pharma Unit-VII Receives FDA VAI Classification
Aurobindo Pharma Unit-VII Gets US FDA VAI Classification Aurobindo Pharma's Unit-VII oral solid dosage facility in Telangana receives Voluntary Action Indicated (VAI) classification from US FDA, closing the inspection with 9 Form 483 observations. AUROPHARMA 1,471.60 43.50 (3.05%)
Bacteria: Unsung Players in the Tumor Microbiome
Recent consensus research highlights that every tumor harbors its own low‑biomass microbiome, influencing cancer development, metastasis, and treatment response. Researchers, led by Maria Rescigno, emphasize the need for rigorous detection methods—favoring 16S rRNA sequencing and culturomics—to distinguish genuine microbes from...
Wellness Briefing: Ritual Calls on Consumers to Pressure DC Lawmakers Towards Supplement Regulation Reform, Plus News
Ritual’s new “We’re expecting” campaign asks consumers to pressure Washington lawmakers to tighten supplement regulation, targeting heavy‑metal contamination and unverified clinical‑testing claims. The company’s CEO Kat Schneider and chief impact officer Lindsay Dahl highlighted the push as part of a...
The Hidden Data Discovery Problem Inside Modern Healthcare Enterprises
Healthcare enterprises are hitting a hidden bottleneck: finding and trusting the right data before any analytics or AI work can begin. Avinash Maddineni notes that teams often spend one to two weeks digging through stale catalogs and manually tracing lineage,...
Some Antibiotics Alter Gut Microbiome Composition for Up to 8 Years
A large Swedish cohort study published in Nature Medicine shows that a single course of antibiotics can reshape the gut microbiome for up to eight years, reducing bacterial diversity and altering species composition. The impact is strongest with broad‑spectrum drugs...
FDA Clears IND for Cellenkos' CK0802, First‑in‑Class Treg Therapy for Steroid‑Refractory GVHD
Cellenkos announced that the U.S. FDA has cleared its Investigational New Drug application for CK0802, enabling a multicenter Phase 1b/2a study in steroid‑refractory graft‑versus‑host disease. The trial, set to begin in the second half of 2026, aims to assess safety...
DOJ Launches West Coast Healthcare Fraud Strike Force to Target Medicare Abuse
The U.S. Department of Justice announced a new West Coast healthcare fraud strike force, linking the DOJ’s fraud unit with U.S. attorney offices in Arizona, Nevada and the Northern District of California. The unit will focus on Medicare and Medicaid...
Lupin Secures FDA Approval for Generic Glycerol Phenylbutyrate Oral Liquid for UCDs
Lupin Limited won U.S. FDA clearance for its glycerol phenylbutyrate oral liquid, a generic version of Horizon Therapeutics' Ravicti, to treat chronic urea cycle disorders. The approval gives patients a new, potentially lower‑cost option and marks Lupin's expanding footprint in...
FDA Grants First Oral SERD Approval to Arvinas' Vepdegestrant for ESR1‑Mutant Breast Cancer
The FDA approved Arvinas' oral selective estrogen receptor degrader (SERD) vepdegestrant for ESR1‑mutant advanced breast cancer, citing a hazard ratio of 0.57 and a median progression‑free survival of 5.0 months versus 2.1 months on fulvestrant. The decision came five weeks...
“Sounds Great. Do You Want FDA Approval?” A Regulatory Analysis of Psychedelics
On April 18, 2026 President Trump signed an executive order compelling the FDA to prioritize review of psychedelic drugs, issuing priority‑review vouchers for three compounds already holding Breakthrough Therapy designation. The order also creates a Right‑to‑Try pathway for ibogaine, directs...
GLP‑1 Drugs Boost Weight Loss and Health, Not Replace Lifestyle
Yes, GLP-1 meds help reduce your weight though a calorie deficit Yes, they have metabolic effects beyond this that help with various health conditions (CVD, psoriasis, alcohol abuse, etc). No, they don’t replace lifestyle changes. Yes, they help you make...
Texas Doctor Found Guilty For Illegally Distributing Millions Of Opioid Pills
A federal jury in Texas convicted Dr. Barbara Marino, the sole prescriber at Angels Clinica, of illegally distributing more than one million opioid and muscle‑relaxant pills through a cash‑only pill mill. Prosecutors said Marino earned roughly $400,000 in under a...
World's First Vaccine for Lyme Disease Could Be Available in 2027
Pfizer and French partner Valneva announced that their Lyme disease vaccine candidate PF‑07307405 (LB6V) achieved 73.2% efficacy in Phase III trials involving more than 9,000 participants. Although the study missed its primary statistical endpoint due to a low incidence of cases,...
Manulife Pledges C$500,000 to Boost Youth Mental‑Health Prevention in Quebec
Manulife announced a C$500,000 (about $365,000 USD) donation to the Youth In Mind Foundation to broaden school‑based mental‑health prevention programs across Quebec. The funding will reach roughly 55,000 youths aged 11‑18 and provide new tools for parents and educators, underscoring...
HHS Threatens to Withhold Millions From Hospitals Over Non‑Compliant Patient Meals
Health and Human Services Secretary Robert F. Kennedy Jr. announced that hospitals serving meals that violate the 2025‑30 USDA dietary guidelines risk losing millions in Medicare and Medicaid reimbursements. The move, framed as a “federal mandate,” has ignited pushback from...
Northwestern Study Finds 796 Fathers Die Within Five Years of Their Child's Birth, 60% Preventable
Northwestern University researchers analyzed 130,267 Georgia births from 2017 and identified 796 paternal deaths within five years, 60% of which were preventable. The findings, published in JAMA Pediatrics, call for expanded mortality tracking beyond mothers.
FDA Expands Compassionate Use of Daraxonrasib for Metastatic Pancreatic Cancer
The U.S. FDA has approved an expanded‑access protocol for daraxonrasib, Revolution Medicines' KRAS‑G12D inhibitor, allowing patients with pretreated metastatic pancreatic cancer to receive the drug. The decision follows phase‑3 data that doubled survival versus standard second‑line chemotherapy, addressing a disease...
Converge Bio’s AI Platform Doubles Cetuximab Affinity in Eight Hours
Converge Bio announced that its generative‑AI platform ConvergeAB produced a cetuximab antibody with more than double the binding strength to EGFR in an eight‑hour, zero‑shot experiment. The result, filed as a provisional patent, highlights AI’s capacity to accelerate and refine...
The Healthcare Investment That’s Right Under Our Noses
The article argues that poor indoor air quality (IAQ) is a hidden health crisis in Australia, worsening chronic diseases, spreading infections, and reducing productivity across schools, workplaces, hospitals and homes. It highlights that one‑in‑two Australians live with chronic conditions, making...
UnitedHealth, Cigna, Humana Post Strong Q1 Earnings, Boost Health‑Insurance Sector
UnitedHealth Group, Cigna and Humana each reported first‑quarter earnings that topped analyst expectations, lifting sentiment in the large‑cap health‑insurance space. The beats were driven by milder flu activity, tighter pricing and stronger medical reserves, though analysts warn the second quarter...
Infoway Fires Michael Green Amid E-Prescribe Fiasco
Canada Health Infoway’s board abruptly terminated CEO Michael Green after the PrescribeIT e‑prescribing platform collapsed, despite receiving roughly US$220 million in federal funding. Launched in 2017 to replace faxed prescriptions, the system saw less than 5 % adoption and is slated to...
Southlake Offers New Model of Care with Satellite Facilities
Southlake Health has issued a request for expressions of interest to develop an advanced care centre in Georgina, part of its newly endorsed Distributed Health Network (DHN) vision. The DHN will add community‑based facilities to two existing hospitals, aiming to...
Quebec May Not Standardize on Epic Province-Wide
Quebec’s health ministry has halted plans to adopt Epic Systems for a province‑wide electronic health record, citing soaring costs and privacy worries. The two pilot projects slated for May 9 now cost roughly $298 million USD, up from an initial $196 million...
GenAI Already a Major Component of Care Delivery
A CSA Group report authored by Will Falk argues that Canada must accelerate supervised adoption of generative AI in healthcare. The paper cites current clinician use for documentation and patient‑facing tools for explanation and navigation. It warns that delaying implementation...
Solera Health Study Shows $1,241 Per-Member Savings and 2.42‑to‑1 ROI
Solera Health reported that its curated digital‑health network cut total cost of care by $1,241 per member over six months and generated a 2.42‑to‑1 return on investment in a matched‑control study of 16,499 enrollees. The findings, validated by an independent...
Rethink Drug Value Through Quality‑of‑Life Lens
Why aren’t the drugs worth it? Because a diseased person’s adjusted quality of life is low. So their life isn’t worth much. Therefore the drugs aren’t worth much since they don’t save a valuable life. It’s an interesting world view. If we’re...
Young Gut Microbes Fail
Gut microbiota transplantation from young adult mice fails to restore low bone and muscle mass in old mice https://t.co/BXKJo3Ovi6 https://t.co/JZ3O4BqXd6
Janus Nanomotors Offer Active Delivery for Radiation‑Induced Dermatitis
A team of nanotech researchers has introduced Janus nanomotors that autonomously move through irradiated skin to deliver anti‑inflammatory drugs, markedly reducing radiation‑induced dermatitis in animal studies. The technology converts skin‑generated hydrogen peroxide into propulsion, enabling targeted therapy with minimal systemic...
New Alcohol Labels May Encourage Reduced Drinking, Study Finds
Updated alcohol warning labels may prompt people to cut back, study suggests https://t.co/tCn8atqLVR #health #lifestylemedicine #alcohol
Winner Announced for Cancer Screening Challenge
MaRS Discovery District and the Canadian Cancer Society announced Gateway Centre of Excellence in Rural Health as the grand‑prize winner of the Rural and Remote Community Cancer Screening Challenge. The Ontario‑based nonprofit received a $100,000 prize (≈US$73,000) to expand its...